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INVESTIGATION
Synthetic Ligands of Cannabinoid Receptors Affect
Dauer Formation in the Nematode
Caenorhabditis elegans
Pedro Reis Rodrigues,* Tiffany K. Kaul,* Jo-Hao Ho,† Mark Lucanic,‡ Kristopher Burkewitz,§
William B. Mair,§ Jason M. Held,**,†† Laura M. Bohn,† and Matthew S. Gill*,1
*Department of Metabolism and Aging and †Department of Molecular Therapeutics, The Scripps Research Institute,
Jupiter, Florida 33458, ‡The Buck Institute for Research on Aging, Novato, California 94945, §Department of Genetics
and Complex Diseases, School of Public Health, Harvard University, Boston, Massachusetts 02115, and **Division of
Oncology and ††Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110
ABSTRACT Under adverse environmental conditions the nematode Caenorhabditis elegans can enter an
alternate developmental stage called the dauer larva. To identify lipophilic signaling molecules that inﬂu-
ence this process, we screened a library of bioactive lipids and found that AM251, an antagonist of the
human cannabinoid (CB) receptor, suppresses dauer entry in daf-2 insulin receptor mutants. AM251 acted
synergistically with glucose supplementation indicating that the metabolic status of the animal inﬂuenced
the activity of this compound. Similarly, loss of function mutations in the energy-sensing AMP-activated
kinase subunit, aak-2, enhanced the dauer-suppressing effects of AM251, while constitutive activation of aak-2
in neurons was sufﬁcient to inhibit AM251 activity. Chemical epistasis experiments indicated that AM251 acts
via G-protein signaling and requires the TGF-b ligand DAF-7, the insulin peptides DAF-28 and INS-6, and a
functional ASI neuron to promote reproductive growth. AM251 also required the presence of the SER-5
serotonin receptor, but in vitro experiments suggest that this may not be via a direct interaction. Interestingly,
we found that other antagonists of mammalian CB receptors also suppress dauer entry, while the nonselective
CB receptor agonist, O-2545, not only inhibited the activity of AM251, but also was able to promote dauer entry
when administered alone. Since worms do not have obvious orthologs of CB receptors, the effects of synthetic
CBs on neuroendocrine signaling inC. elegans are likely to be mediated via another, as yet unknown, receptor






During development, Caenorhabditis elegans can enter an alternate
larval stage, called the dauer larva, that allows the animal to survive
adverse environmental conditions, such as high temperature, low food
availability, and high population density (Golden and Riddle 1984a).
Genetic analysis of dauer formation has deﬁned neuroendocrine signals
that act through a TGF-b-like signaling and an insulin-like signaling
pathway, which converge on the cytochrome P450 DAF-9 and the
nuclear receptor DAF-12 (Hu 2007). The identiﬁcation of dafachronic
acids (Motola et al. 2006) and other sterol acids (Held et al. 2006,
Mahanti et al. 2014), which are produced by DAF-9 and act as ligands
for DAF-12, conﬁrmed the existence of lipophilic hormones that act
downstream of TGF-b and insulin signaling to instruct the decision
to proceed with reproductive growth. Likewise, the identiﬁcation of
ascarosides (ascr) as the bioactive components of dauer-inducing pher-
omone (Ludewig and Schroeder 2013) has conﬁrmed the existence of
small molecules that inﬂuence the activity of the neuroendocrine path-
ways in response to environmental conditions.
Evidence for small molecule signals that act through G protein-
coupled receptors (GPCRs) tomodulate dauer formation initially came
from genetic evidence. daf-11, a guanylyl cyclase expressed in a subset of
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neurons, has a strong dauer constitutive (Daf-c) phenotype and was
implicated in second messenger signaling downstream of chemosensory
signaling and G-proteins (Birnby et al. 2000, Bargmann 2006). Further-
more, mutations in a subset of the nematode G protein subunits confer
insensitivity to dauer pheromone (Lans and Jansen 2007, Zwaal et al.
1997, Lewis and Hodgkin 1977). The identiﬁcation of ascarosides as the
bioactive components of dauer pheromone further conﬁrmed the role of
GPCR signaling in modulating dauer entry. Two GPCRs, SRBC-64 and
SRBC-66, have been shown to bind both ascr#2 and ascr#3 to induce
dauer formation and likely function upstream of TGF-b and insulin-like
signaling (IIS) (Kim et al., 2009). Two other GPCRs, DAF-37 and DAF-
38, have been shown to bind ascr#2 to promote dauer formation
by repressing TGF-b signaling (Park et al. 2012). Likewise, srg-36 and
srg-37 are GPCRs that are expressed in the sensory cilia of ASI neurons
and mutations in these genes confer resistance to ascr#5, suggesting
that they might bind this molecule to induce dauer formation
(O’Rourke et al. 2013).
While ascaroside signaling is concernedwithpromotingdauer entry,
food signals from the environment promote reproductive growth
(Golden and Riddle 1984b). In contrast to pheromone signaling, much
less is known about the identity of environmental food signals and their
signaling mechanisms. We have previously determined that bacterial
fatty acids can promote recovery from the dauer stage via a mechanism
that is dependent on daf-11 (Kaul et al. 2014), suggesting that food
signals may alsomediate their effects viaGPCR signaling. In addition to
small molecules that are sensed from the environment, it is likely that
other endogenous smallmolecules contribute to the decision to proceed
with reproductive growth or enter dauer. Indeed, we have previously
found that a molecule from the N-acyl ethanolamine class of bioactive
lipids can promote reproductive growth under dauer-inducing condi-
tions (Lucanic et al. 2011). The existence of 80 cytochrome P450s
(Menzel et al. 2001), which have the potential to synthesize small
molecules, along with 284 nuclear receptors (Gissendanner et al.
2004, Robinson-Rechavi et al. 2005, Van Gilst et al. 2002), as well as
over 1000 predicted G-protein coupled receptors in the C. elegans
genome (Keating et al. 2003, Robertson and Thomas 2006), indicates
that there are likely to be many more pathways that are responsive to
smallmolecules in the worm.Despite this, we still know very little about
the identity of other lipophilic hormones or small molecules that affect
dauer formation or other phenotypes in the worm.
In this study, we took a screening approach, using a small library of
bioactive lipids and related compounds, to identify small molecules that
could promote reproductive growth in Daf-c mutants. We found that
AM251, an inverse agonist/antagonist of the mammalian CB receptor
(Gatley et al. 1996), suppressed dauer formation in daf-2 insulin
receptor mutants, by acting through G-protein signaling to activate
TGF-b and insulin peptide pathways in the ASI chemosensory neuron.
Since C. elegans does not possess obvious orthologs of the mammalian
CB receptors (McPartland 2004, McPartland et al. 2006), AM251 likely
acts via a different receptormechanism.However, we also observed that
a number of other synthetic CBs, both antagonists and agonists, also
affect dauer formation, raising the possibility that the worm expresses
a novel CB-like receptor that has conserved function but sequence
divergence compared with the canonical mammalian CB receptors.
MATERIALS AND METHODS
Chemicals
AM251, SR141716A (Rimonabant), URB447, LH21, AM630, O-2545,
and CP55,940 were obtained from Cayman Chemical (Ann Arbor, MI)
and Gp1a was obtained from Tocris Bioscience (Minneapolis, MN).
C. elegans maintenance and strains
C. elegans strains were maintained as previously described (Brenner
1974). The following strains were obtained from the Caenorhabditis






(pk342)], RB2277[ser-5(ok3087)], MT15434[tph-1(mg280)], PY6560
[srbc-64(tm1946)], and PY6523[srbc-66(tm2943)]. aak-2(ok524) was
backcrossed to wild type N2 ﬁve times. Constitutively active (CA)
AMPK strains—global expression - uthIs248[aak-2p::aak-2 genomic
(aa1-321)::GFP::unc-54 39UTR]; neuronal expression - wbmEx66
(rab-3p::aak-2 (aa1-321 cDNA)::tdTomato::unc-54 39UTR); intestinal
expression -wbmEx67(gly-19p::aak-2 (aa1-321 cDNA)::tdTomato::unc-54
39UTR); muscle expression - wbmEx68(myo-3p::aak-2 (aa1-321
cDNA)::tdTomato::unc-54 39UTR)—were generated as previously
described (Burkewitz et al. 2015). ins-6(tm2416) and daf-28
(tm2308) were obtained from Dr. Shohei Mitani at the National
Bioresource Project at Tokyo Women’s Medical University School
of Medicine and were backcrossed ﬁve times to N2.
The ins-6 and daf-28 mutants were each crossed into daf-2(e1371)
as previously described (Kaul et al. 2014). All other double mutants
were generated by standard methods and crosses were conﬁrmed by
PCR genotyping or sequencing where applicable.
The ASJ ablation strains jxEx18[unc-122p::GFP] and daf-2(e1368);
jxEx100[pQZ37(trx-1p::ICE); unc-122p::GFP] were a kind gift from
Dr. Joy Alcedo (Cornils et al. 2011). For ablation of the ASI neuron,
2 kb of the gpa-4 promoter was inserted upstream of human caspase in
the pV32 plasmid (a kind gift from V. Maricq) using PstI and KpnI
restriction sites. To generate transgenic animals, daf-2(e1368) worms
were injected with pPV32 gpa-4p::ICE (30ng/ml) and a myo-2p::GFP
coinjection marker (5 ng/ml), and a daf-2(e1368);jluEx122(gpa-4p::
ICE; myo-2p::GFP) stable line was identiﬁed through myo-2p::GFP
expression.
Dauer assays
Dauer assays were performed as previously described (Held et al. 2006).
Compounds were resuspended in DMSO to a ﬁnal concentration of
20mM. For dose range experiments, serial dilutions weremade to yield
10, 5, 2, 1, and 0.5 mM. 15 mL of each working solution of compound
were added to 135 mL of water before being spotted onto a 4 mL NGM
plate. Equal distribution of the compound throughout the agar was
assumed to yield ﬁnal concentrations of 50, 25, 10, 5, and 2.5 mM.
For the dauer shift assay, eggs from a synchronous lay were trans-
ferred to plates containing DMSO and placed at 25. At different time
intervals after the lay, worms were removed from the incubator and
transferred to plates containing AM251 and returned to the incubator
as quickly as possible. Two separate lays were performed, one in the
morning and one in the evening such that one lay would yield the 24 hr
and 30 hr time points and the other lay would yield the 12 hr and 18 hr
time points. For glucose assays, glucose was added to the molten NGM
prior to pouring plates and dauer assays performed as described above.
SER-5/b-arrestin2 recruitment assay
C. elegans ser-5 cDNA was ampliﬁed with a 59 XhoI and a 39 KpnI site
and cloned into pCMVHA-N (Clontech). The b-arrestin2 recruitment
assaywas performed as previously described (Barak et al. 1997, Johnson
et al. 2003). Brieﬂy, HEK cells were transfected with HA-ser-5 (5 mg)
1696 | P. Reis Rodrigues et al.
and mouse b-arrestin2-EGFP (2 mg) using the Gene Pulser Xcell elec-
troporation system (Bio-Rad). After transfection, cells were plated on
collagen-coated glass-bottom dishes and incubated overnight. Cells
were then serum starved in Opti-MEM media without phenol red for
60 min. An Olympus FluoView 1000 confocal microscope was used to
image b-arrestin2-EGFP translocation in live cells. Single focal plane
images were captured using 100X objective after serum starvation for
basal activity, and between 5 and 60 min after drug treatment. To
ensure cells that were not stimulated by AM251 were able to respond
to drug treatment, cells were treated with 10mM serotonin after AM251
treatment.
Statistical analysis
The percentages of dauers and nondauers were calculated for each
trial, and trials set up on different days were deemed to be biological
replicates. Statistical analysis was performed using GraphPad Prism.
Data are presented asmean+ sd andwere analyzed by Student’s t-test
for k = 2 groups or one-way ANOVA for k $ 3 groups with Sidak’s
multiple comparisons test for pairwise comparisons.
Data availability
All strains and vectors generated are available upon request. All data
necessary for conﬁrming the conclusions presented in the article are
available in Supplementary Material, File S1.
RESULTS
The CB receptor antagonist AM251 suppresses dauer
formation in C. elegans
To identify lipid signaling molecules that suppress dauer entry in
C. elegans, we screened the Bioactive Lipid Library (Enzo Life Sciences)
in a daf-2(e1371) mutant background at 25. Of the 204 compounds
screened, only one compound, AM251 (Figure 1A), robustly promoted
growth of daf-2mutants to the gravid adult stage under dauer-inducing
conditions. To conﬁrm the activity of AM251, we carried out dose
response experiments and found that this molecule reproducibly pro-
moted growth of daf-2 mutants to adulthood in a dose-dependent
manner, with 5mMAM251 sufﬁcient to rescue almost 100%of animals
(Figure 1B).
AM251 acts early in development to promote
reproductive growth
To examine the timing requirement for AM251, daf-2(e1368) ani-
mals from a synchronous egg lay were raised at 25 on plates contain-
ing DMSO vehicle (dauer-inducing conditions) and transferred to
plates containing AM251 at different time points. Worms that were
transferred to AM251 at 12 hr or 18 hr after the egg lay developed
into adult, nondauer animals in the same way as the AM251 control
(Figure 1C). However, worms that were transferred from DMSO to
AM251 at 24 hr and 30 hr after the egg lay continued to develop into
dauers, as did animals that were only exposed to DMSO. Con-
versely, worms raised on AM251 and shifted to DMSO at 12 hr or
18 hr after the egg lay developed into dauers in the same way as the
DMSO control (Figure 1D), but worms that were transferred from
AM251 to DMSO at 24 hr and 30 hr after the egg lay developed into
reproductive adults, as did animals that were only exposed to
AM251. These data show that AM251 exposure in late L1/early
L2 is required and sufﬁcient to promote reproductive growth. In
addition, the failure of AM251 to promote reproductive growth in
animals shifted after 24 hr suggests that it cannot alter the fate of
L2d/predauer animals.
AM251 activity is augmented by
glucose supplementation
Supplementation with glucose has been shown to rescue the Daf-c
phenotype of daf-2 mutants at semipermissive temperatures (Lee
et al. 2009, Mondoux et al. 2011), via a mechanism that involves
O-linked-N-acetylglucosamine (O-GlcNac) cycling (Forsythe et al. 2006,
Hanover et al. 2005, Lee et al. 2010). We therefore asked whether
AM251 promotes reproductive growth via a similar mechanism. At
the restrictive temperature of 25, exposure to 100 mMD-glucose pro-
moted reproductive growth in only 10% of animals (Figure 2A). Under
these conditions, 5 mM AM251 alone resulted in approximately 70%
rescue, with lower doses showing very little effect (Figure 2A). How-
ever, combined exposure to glucose and AM251 resulted in a dose-
dependent, synergistic increase in the number of nondauer animals
(Figure 2A). This effect required metabolism of glucose, since in the
presence of L-glucose, which cannot be metabolized, there was no
additional effect over that of AM251 alone (Figure 2B). Loss of function
mutations in the O-GlcNac transferase ogt-1 lead to decreased
O-GlcNacylation of proteins and diminished the ability of glucose to
suppress dauer formation in daf-2 mutants (Mondoux et al. 2011).
However, AM251 was still able to rescue dauer formation in a daf-2;
ogt-1 mutant background (Figure 2C). Collectively, these data suggest
that AM251 and glucose promote reproductive growth via parallel
mechanisms, and also indicate that the activity of AM251 is inﬂuenced
by the metabolic status of the animal.
Neuronal AMPK activity inhibits the effects of AM251
The AMP regulated kinase, AMPK, is an important sensor of cellular
energy levels and an increase in the AMP to ATP ratio arising from low
nutrition results in phosphorylation and activation of AMPK (Hardie
2011). In C. elegans, loss of function mutations in one of the AMPK a
subunits, aak-2, behave like AM251 treatment and suppress dauer
entry in daf-2 mutants at 25 (Apfeld et al. 2004). Thus, we reasoned
that if AM251 was inhibiting AMPKactivity, there should be no further
suppression of the Daf-c phenotype in daf-2; aak-2 mutants treated
with AM251. Contrary to this, we found that AM251 was fully effective
in promoting reproductive growth in daf-2(e1368); aak-2(ok524)
double mutants at 26.5 (Figure 3A). This suggests that AM251 is
not acting via inhibition of AAK-2, but rather that AAK-2 activity
may limit the dauer rescuing activity of this molecule.
If wild-type AMPK activity limits the effectiveness of AM251, we
reasoned that constitutively active AAK-2 should further inhibit the
ability of AM251 to suppress dauer formation.We therefore introduced
a constitutively active version of AMPK, aak-2(CA) (Mair et al. 2011),
into the daf-2mutant background and asked whether AM251 was still
able to suppress dauer formation. There was no increase in the basal
level of dauer formation in the daf-2; aak-2(CA) animals, and while
they did respond to AM251 in a dose-dependent manner, there was a
signiﬁcant reduction in the magnitude of the response compared with
daf-2 controls (Figure 3B). These data show that constitutive activation
of AMPK inhibits the ability of AM251 to suppress dauer formation by
a parallel mechanism.
To determine where AAK-2(CA) acts to inhibit AM251, we
expressed it in different tissues and examined the ability of AM251
to suppress dauer entry in daf-2 mutants. AM251 was still able to
suppress dauer formation in daf-2 mutants with activated AMPK in
either the intestine or in body wall muscle, but was unable to promote
reproductive growth to the same extent when AMPK was activated in
neurons (Figure 3C). These data indicate that AAK-2 activity in neu-
ronal tissues antagonizes the growth promoting activity of AM251 and
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are consistent with AM251 acting through a neuronal mechanism to
inhibit dauer formation.
AM251 acts via TGF-b signaling and insulin peptides in
the ASI neuron
Laserablationstudieshave identiﬁedanumberof sensoryneurons that are
involved in dauer entry and exit (Bargmann andHorvitz 1991). Of these,
the ASI neuron plays amajor role in promoting reproductive growth and
inhibiting dauer entry, with a lesser role for the ASJ neuron (Bargmann
and Horvitz 1991), and thus ASI is a strong candidate for mediating the
effects of AM251. Therefore, we examined dauer entry in response to
AM251 in daf-2 mutants in which either the ASI or ASJ neuron was
ablated through tissue speciﬁc expression of a cytotoxic caspase (Cornils
et al. 2011). Ablation of the ASI neuron strongly reduced the ability of
AM251 to promote reproductive growth (Figure 4A), but loss of the ASJ
neuron had no effect (Figure 4B). These data show that the effect of
AM251 in suppressing dauer entry is mediated via the ASI neuron.
TheASI neuron promotes reproductive growth via the secretion of the
TGF-b ligand DAF-7 (Ren et al. 1996), as well as insulin peptides, such as
DAF-28 (Li et al. 2003) and INS-6 (Cornils et al. 2011). We therefore
tested if AM251 was acting through these pathways to promote repro-
ductive growth.We found that AM251 did not rescue dauer formation in
daf-7 mutants, which lack a TGF-b ligand, nor did it have any effect on
daf-4mutants, which have a defective TGF-b receptor (Figure 4C). These
data show that AM251 requires a functional TGF-b signaling pathway for
its effect on dauer formation. We also tested the requirement for daf-28
and ins-6 because they are expressed early in larval development (Baugh
et al. 2011) and both have previously been implicated in dauer formation
(Li et al. 2003, Cornils et al. 2011). AM251 was able to suppress
dauer formation in ins-6(tm2416); daf-2(e1371) and daf-2(e1371); daf-28
(tm2308) double mutants at 25, although the response was signiﬁcantly
reduced compared with daf-2 alone and was more pronounced in the
daf-2; daf-28 double mutant (Figure 4D). These data are consistent
with the assertion that daf-28 is more important than ins-6 in promoting
reproductive growth (Cornils et al. 2011), but suggest that AM251
inﬂuences secretion of both insulins. AM251 also failed to promote re-
productive growth in an ins-6(tm2416);daf-2(e1371);daf-28(tm2308) triple
mutant, but we were concerned that the strong Daf-c phenotype (95%
dauers at 15) would obscure the interpretation of dependency (data not
shown). We therefore examined whether AM251 could prevent dauer
formation in an ins-6; daf-28 double mutant in the presence of a wild-
type daf-2 receptor. ins-6(tm2416); daf-28(tm2308) double mutants are
Daf-c at 27 (Cornils et al. 2011), andwe found that AM251was unable to
rescue the Daf-c phenotype of the double mutant at either fully restrictive
or semipermissive temperatures (Figure 4E). This result suggests that
insulin peptide secretion after exposure to AM251 is required for pro-
moting reproductive growth. To further test this, we evaluated the effect
of AM251 in unc-31 mutants that lack a calcium activated protein for
secretion (CAPS) homolog that is required for DAF-7 and insulin secre-
tion via dense core vesicle docking (DCV) (Ailion et al. 1999, Speese et al.
2007). Consistentwith a neurosecretorymechanism,we found thatAM251
had no effect on the Daf-c phenotype of unc-31mutants at 27 (Figure 4F).
G-protein signaling mediates the effects of AM251 on
dauer formation
The guanylyl cyclase DAF-11 is expressed in the ASI neuron and has
been shown to be required for both TGF-b and insulin peptide expres-
sion (Li et al. 2003, Murakami et al. 2001). AM251 was not able to
promote reproductive growth in daf-11 mutants (Figure 5A), suggest-
ing that it requires functional DAF-11 to promote secretion of
Figure 1 The cannabinoid (CB) receptor antagonist AM251 suppresses dauer formation. (A) Structure of the CB1 receptor antagonist/inverse
agonist AM251. (B) AM251 promotes reproductive growth in daf-2(e1371) mutants at 25 in a dose-dependent manner. (C) daf-2(e1368) worms
raised on DMSO (D, dimethyl sulfoxide) and transferred to AM251 (A) up to 24 hr after the egg lay develop into reproductive adults, while worms
transferred at 24 hr, or later, are committed to dauer formation and AM251 has no effect. (D) daf-2(e1368) worms raised on AM251 (A) and transferred
to DMSO (D) up to 24 hr after the egg lay develop into dauers while worms maintained on AM251 for 24 hr or 30 hr and then transferred are
committed to reproductive growth and the absence of AM251 has no effect.
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neuropeptides from the ASI neuron. Since daf-11 is hypothesized to
work downstream of GPCR signaling (Birnby et al. 2000, Bargmann
2006), we tested if G-protein subunits are required for the effects of
AM251.We focused on those G-proteins that are expressed in the ASI
neuron, and crossedmutants into the daf-2(e1368) background to eval-
uate their effects on the ability of AM251 to suppress dauer formation.
Of the seven G-proteins tested, we found that only gpa-3 is partially
required for the effects of AM251 (Figure 5B). This indicates that gpa-3
is functioning upstream of TGF-b and insulin secretion and impacts
the ability of AM251 to promote reproductive growth.
AM251 requires the serotonin receptor ser-5 to
suppress dauer formation
As C. elegans lacks orthologs of CB receptors (McPartland 2004,
McPartland et al. 2006), it is likely that AM251 acts through another
receptor type to inﬂuence dauer formation. We considered the seroto-
nin receptor ortholog ser-5 to be a strong candidate, as a previous study
had shown that ser-5 inﬂuences dauer exit by modulating AMPK
activity and dense core vesicle secretion (Cunningham et al. 2014).
Consistent with a requirement for ser-5, we found that AM251 was
unable to promote reproductive growth in ser-5;daf-2 double mutants
(Figure 5C). Interestingly, we found that AM251was able to fully rescue
dauer formation in tph-1;daf-2 doublemutants, which lack the ability to
synthesize serotonin (Figure 5C). This suggests that AM251 is not
acting through SER-5 by simply modulating the availability of its
ligand.
To directly test whether AM251 had functional activity at SER-5, we
employed a b-arrestin2 translocation assay in HEK-293T cells (Barak
et al. 1997, Johnson et al. 2003). We coexpressed HA-tagged SER-5 and
mouse b-arrestin2 fused to EGFP, in order to ask if AM251 was able to
elicit b-arrestin2 recruitment to the cell surface. As a positive control
we treated cells with 10 mM 5-HT, and observed the formation of
b-arrestin2-EGFP puncta close to the cell membrane, demonstrating
that 5-HT is an agonist of SER-5 (Figure 5, D and E). In addition, HA
staining of HA-SER-5 transfected cells revealed an increase in internal-
ized SER-5 after serotonin treatment providing further evidence that
5-HT is an agonist at SER-5. Treatment with 10 mMAM251, however,
had no effect on the localization of b-arrestin2-EGFP, indicating that
AM251 is not an agonist at SER-5. Moreover, AM251 was not able to
reverse 5-HT stimulatedb-arrestin2-EGFP recruitment, nor was it able
to block subsequent 5-HT activity, demonstrating that AM251 is also
not an antagonist at SER-5. Together, these data suggest that AM251
does not have functional activity at SER-5.
Multiple CB receptor ligands modulate dauer formation
Although it is likely that AM251 acts through a non-CB receptor
mechanism, it also remains a possibility that worms possess a functional
ortholog of CB receptors. In support of this latter hypothesis, we found
that a number of other CB receptor antagonists were capable of
suppressing dauer formation in daf-2 mutants. These include the
silent CB1 antagonist LH21 (Jagerovic et al. 2004), the selective CB2
antagonist AM630 (Ross et al. 1999), as well as the mixed central CB1
receptor antagonist/peripheral CB2 agonist URB447 (LoVerme et al.
2009) (Figure 6, A–C). We also examined a number of CB receptor
agonists for their ability to inhibit the actions of AM251 in suppressing
dauer formation. Worms were exposed to increasing concentrations of
the agonists in the presence of 2.5 mM AM251, a dose that is capable
of rescuing dauer formation in the majority of animals. O-2545, a
water soluble analog of the main psychoactive component of can-
nabis, D9-tetrahydrocannabinol, and a nonselective CB1/2 receptor
agonist (Martin et al. 2006), was able to potently suppress AM251-
mediated reproductive growth (Figure 6D). The CB2 receptor ago-
nist GP1a (Murineddu et al. 2006) was also able to block the effects
of AM251 to a lesser extent (Figure 6E), while another nonselective
CB1/2 receptor agonist, CP55,940 (Pertwee 1999), had no effect
(Figure 6F).
TheabilityofO-2545toprevent the effectsofAM251 ledus to further
examine whether it was able to induce dauer formation when admin-
istered alone.We found that at the semipermissive temperature of 23.6,
O-2545 did indeed induce a signiﬁcant number of dauers at 10mMand
25 mM, while at higher concentrations it resulted in a signiﬁcant num-
ber of animals that were slow growing or arrested in the early larval
stages (Figure 6G). The ability of O-2545 to induce dauer formation did
not require srbc-64 or srbc-66, suggesting that this CB receptor agonist
was not acting via these ascaroside receptors (Figure 6H).
Figure 2 AM251 activity is augmented by glucose supplementation.
(A) The ability of AM251 to promote reproductive growth in daf-2
(e1368) mutants at 25 is augmented by D-glucose. Pairwise compar-
isons for 0 mM glucose vs. 5 mM glucose and 100 mM glucose at each
dose of AM251 all had P, 0.001, except at 0 mM AM251 where 0 mM
glucose vs. 100 mM glucose had P , 0.01. (B) L-Glucose supplemen-
tation does not enhance the ability of AM251 to promote reproductive
growth in daf-2(e1368)mutants. (C) Deletion of the O-GlcNac (O-linked-
N-acetylglucosamine) transferase, ogt-1(ok430), has no effect on the
ability of AM251 to promote reproductive growth in daf-2(e1368).
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DISCUSSION
We screened a small library of bioactive lipids and identiﬁed the
synthetic mammalian CB1 receptor inverse agonist/antagonist
AM251 as a robust modiﬁer of dauer formation in the worm. CB
receptor antagonists were developed as an antiobesity therapy, with
the hypothesis that inhibition of the CB receptor in the central
nervous system would decrease feeding and thus lead to weight
loss (Carai et al. 2005). One such compound is Rimonabant, a
closely-related analog of AM251, which we also found to suppress
dauer formation in worms, to the same extent as AM251 (data not
shown). In clinical trials, the degree to which Rimonabant promoted
weight loss and the extent of its beneﬁcial effects on lipid proﬁles
suggested that its mechanism went beyond the central inhibition of
food intake (Scheen 2008). There is now evidence that CBs inﬂuence
glucose homeostasis and insulin sensitivity, independently of their
effects in the central nervous system (Juan-Pico et al. 2006, Nogueiras
et al. 2009).
We have generated a number of lines of evidence that suggest that
AM251 also elicits changes in insulin sensitivity in C. elegans, which
leads to suppression of dauer entry. First, AM251 activity required the
presence of the insulin peptides daf-28 and ins-6, as well as unc-31,
which encodes a protein that is required for dense core vesicle docking
and neuropeptide secretion. The daf-2(e1368) and daf-2(e1371) muta-
tions that we used in this study are hypomorphic and alter single amino
acid residues in the extracellular, ligand binding domain of daf-2 (Patel
et al. 2008). Thus, it is likely that these mutants have altered afﬁnity for
insulin peptides, and, consequently, their temperature sensitive Daf-c
phenotypes could be overcome by increases in insulin peptide avail-
ability. Although AM251 also required the TGF-b ligand daf-7, this
could be a consequence of daf-7mutants being functionally deﬁcient in
insulin signaling, rather than a direct action of AM251 on TGF-b
signaling, since daf-7mutations lead to down-regulation of many com-
ponents of the insulin signaling pathway (Liu et al. 2004). Second,
AM251 required an intact ASI neuron, but was not affected by ablation
of the ASJ neuron. ASI is known to be important for promoting
reproductive growth (Bargmann and Horvitz 1991) and expresses
DAF-7, DAF-28, and INS-6 during development (Ren et al. 1996,
Li et al. 2003, Cornils et al. 2011). Third, timing experiments
indicated that AM251 exposure early in development was sufﬁcient
to promote reproductive growth. These data recapitulate the tem-
perature shift experiments of Swanson and Riddle (Swanson and
Riddle 1981), that originally deﬁned the dauer decision window and
indicate that AM251 acts in late L1/early L2. Importantly, this is also
the time at which daf-28 and ins-6 expression peak during develop-
ment (Baugh et al. 2011).
The synergistic interaction between AM251 and glucose in modi-
fying dauer formation is also consistent with AM251 affecting insu-
lin sensitivity. Glucose supplementation prevents dauer entry only
under semipermissive conditions (Lee et al. 2009, Mondoux et al.
2011), and one interpretation of this is that under these conditions
there is enough residual insulin signaling to generate ATP when more
glucose becomes available. However, under fully restrictive condi-
tions, insulin signaling drops below a threshold and metabolism is
shifted away from energy utilization to energy storage (Braeckman
et al. 2009). In this situation, the addition of supplemental glucose
results in increased energy storage and has no effect in promoting
reproductive growth. Thus, at low doses, where AM251 alone is not
able to increase insulin signaling sufﬁciently to prevent dauer entry,
the addition of glucose provides additional substrate to drive catab-
olism and energy production beyond a threshold that is sufﬁcient to
support reproductive growth.
Further evidence that AM251 activity is inﬂuenced by the metabolic
status of the animal comes from its interaction with AMPK signaling.
Loss of function mutations in the aak-2 subunit behave like AM251 in
that they suppress dauer formation in daf-2 mutants (Apfeld et al.
2004). Although epistasis analysis indicated that AM251 does not re-
quire AMPK for its activity, we did ﬁnd that constitutive activation of
aak-2 in neurons was able to block AM251 signaling. This suggests that
the AM251 signaling cascade acts in parallel to energy sensing by
AMPK. In mammals, AMPK activity inﬂuences insulin secretion from
pancreatic b-cells in a number of ways, including glucose metabolism,
K+/ATP channel trafﬁcking, insulin granule docking, and insulin gene
transcription (Fu et al. 2013). Thus, the effect of AMPK activity on
AM251 function may be via its effects on insulin peptide transcription
and/or insulin secretion, rather than directly inhibition of AM251 sig-
naling pathways.
Figure 3 AM251 is inhibited by neuronal AMPK activity. (A) AM251
suppresses dauer formation in daf-2(e1368); aak-2(ok524) mutants at
26.5. (B) The ability of AM251 to suppress dauer formation in daf-2
(e1368) mutants is inhibited by the presence of constitutively active
AAK-2 (daf-2(e1368); aak-2(CA)). (C) Constitutively active (CA) AAK-2 in
neurons, but not in intestine or muscle, inhibits the ability of AM251 to
promote reproductive growth in daf-2(e1368) at 25. For all panels,
pairwise comparisons are indicated:  P , 0.01  P , 0.001. AAK,
AMP-activated kinase subunit; AMPK, AMP regulated kinase.
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The dependence on daf-7, ins-6, and daf-28 also support the idea
that the ASI sensory neuron is a target tissue of AM251. However,
whether this is mediated through a direct interaction with a receptor
expressed on this neuron or indirectly by acting on another neuron,
which in turn inﬂuences ASI activity, remains to be determined.
AM251 also required the activity of the guanylyl cyclase DAF-11,
which is expressed in a subset of amphid sensory neurons, including
ASI (Birnby et al. 2000), and is thought to function downstream of
chemosensory G-protein coupled receptors (Bargmann 2006). In the
absence of CB receptor orthologs, we considered the serotonin receptor
SER-5 to be a good candidate for an AM251 target, principally because
SER-5 had been shown to act in the ASI neuron to inﬂuence dauer
exit by modulating AMPK activity and dense core vesicle secretion
(Cunningham et al. 2014). Genetic experiments indicated that ser-5
was indeed required for the activity of AM251 but, intriguingly,
AM251 did not require the activity of tph-1, which is required for
serotonin synthesis (Sze et al. 2000). This suggests that AM251 is not
acting to modulate serotonin availability at the SER-5 receptor and
raised the possibility that it could directly interact with SER-5. This
hypothesis, however, was not supported by molecular pharmacology
studies. A b-arrestin2 translocation assay, failed to reveal functional
afﬁnity for AM251 and the worm SER-5 receptor. b-arrestin2 acts as a
signaling scaffold for many GPCRs (Orgel 1963) and the translocation
assay provides a means of determining whether a ligand acts through a
target receptor without any knowledge of the subset of G-proteins that
are required (Peters et al. 2012). Importantly, we were able to demon-
strate that 5-HT treatment of cells transfected with HA-SER-5 does
lead to b-arrestin2-EGFP being translocated to the cell surface and
internalization of the receptor, providing direct evidence that 5-HT
does activate SER-5. Unfortunately, we were not able to observe any
effect of AM251 alone on b-arrestin2-EGP recruitment, nor did we see
any evidence that AM251 could compete with 5-HT. Taken together,
these data suggest that AM251might be either functioning upstream of
SER-5 by altering the levels of a non-5-HT-like ligand or, alternatively,
that AM251 acts on a different receptor target that interacts with the
SER-5 receptor. In this respect, it is noteworthy that the mammalian
CB1 receptor has been shown to form heteromers with 5-HT2A recep-
tors (Vinals et al. 2015).
Although we have yet to identify the molecular target of AM251 in
the worm, our data support a model in which AM251 acts upstream of
SER-5 and requires TGF-b and insulin peptides in the ASI neuron to
promote reproductive growth programs throughout the whole animal.
By screening a subset of nematode G-protein mutants, we found that
gpa-3 is required for the effects of AM251, supporting the idea that a
Figure 4 AM251 requires both TGF-b and insulin secretion from the ASI neuron. (A) Genetic ablation of the ASI sensory neuron blocks the ability
of AM251 to suppress dauer formation in the daf-2(e1368)mutant background at 25. (B) Genetic ablation of the ASJ sensory neuron has no effect
on the ability of AM251 to suppress dauer formation in the daf-2(e1368) mutant background at 25. (C) 5 mM AM251 promotes reproductive
growth in daf-2(1368) mutants, but not in daf-7(e1372) or daf-4(e1364) mutants. (D) AM251 rescues the dauer formation phenotype of ins-6
(tm2416); daf-2(e1371) and daf-2(e1371); daf-28(tm2308) double mutants at 25. (E) AM251 does not rescue the dauer formation phenotype of an
ins-6(tm2416); daf-28(tm2308) double mutant at 26.5 or 27. ANOVA by dose: 26.5 P = ns, 27 P = ns. (F) AM251 does not suppress the Daf-c
phenotype of unc-31(e928) mutants at 27. ANOVA by dose P = ns. For all panels, pairwise comparisons are indicated:  P , 0.05,  P , 0.001.
CON, control; ns, not signiﬁcant.
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GPCR signaling is being targeted. Kim et al. (2009) have shown that
gpa-3 mutants are insensitive to ascaroside-induced dauer entry,
perhaps suggesting that AM251 is antagonizing a component of the
system that is involved in dauer formation in response to ascarosides
(Kim et al. 2009). However, the CB receptor agonist O-2545, which
inhibited the effects of AM251 and also promoted dauer formation
when administered alone, was still capable of inducing dauer entry in
the absence of srbc-64 and srbc-66, two GPCRs that have been shown
to mediate the effects of ascarosides on dauer formation in a gpa-3
dependent manner (Kim et al. 2009). Although other ascaroside recep-
tors exist, these data suggest that synthetic CBs are probably not acting
directly on dauer pheromone signaling pathways to modify the dauer
decision.
AM251 was developed as a speciﬁc antagonist of the mammalian
CB1 receptor, but it has since become clear that synthetic CBs are
somewhat promiscuous in terms of the receptor subtypes through
which they mediate their biological effects (Pertwee et al. 2010). As
such, AM251 has also been shown to act on multiple targets, including
GPR55, T-type calcium channels, voltage gated sodium channels, as
well as PPAR a and g (Pertwee et al. 2010). Thus, it is perhaps not
surprising to ﬁnd that AM251 has potent biological effects in an or-
ganism that lacks canonical CB receptors (McPartland et al. 2006),
but is replete with other possible receptor targets that have human
homologs (Shaye and Greenwald 2011). However, it is intriguing that
other, structurally unrelated CB receptor antagonists also suppressed
dauer entry, while CB receptor agonists not only inhibited the effects of
AM251, but one of them was able to elicit the opposite phenotype and
promote dauer entry when administered alone. Of the antagonists, the
CB1 speciﬁc compounds, AM251 (Lan et al. 1999) and LH21 (Jagerovic
et al. 2004), were most potent, followed by the selective CB2 antagonist
AM630 (Ross et al. 1999), while themixedCB1 antagonist/CB2 agonist,
URB447 (LoVerme et al. 2009), showed the weakest effects. Of the
Figure 5 AM251 functions upstream of gpa-3 and ser-5 to suppress dauer formation. (A) AM251 does not prevent dauer formation in daf-11(m47)
mutants. (B) The gpa-3 G-protein subunit is partially required for AM251 to prevent dauer formation in daf-2(e1368) mutants. (C) AM251 requires
the serotonin receptor ser-5 to prevent dauer formation in the daf-2(e1368) background, but is not affected by the loss of tph-1. (D) Heterologous
expression of HA-tagged SER-5 and mouse b-arrestin2-EGFP in HEK 293T cells. Incubation with 10 mM 5-HT for 20–35 min robustly induced
b-arrestin2-EGFP (green punctae) recruitment to cell surface membranes of HEK-293T cells expressing HA-SER-5 (red). As is typical for GPCRs
including mammalian serotonin receptors, internalization of the receptors can also be detected following serotonin treatment (intracellular red
punctae). Addition of AM251 did not reverse serotonin-induced b-arrestin2-EGFP translocation or receptor internalization, suggesting that it is
not acting as an antagonist at the receptor. (E) In contrast, b-arrestin2-EGFP recruitment was not observed in cells treated with 10 mM AM-251 for
20–35 min and this treatment failed to prevent 10 mM 5-HT induced b-arrestin2-EGFP recruitment and HA-SER-5 internalization, again, suggest-
ing that AM251 does not act as an antagonist at this receptor. The experiment was performed over three individual transfections of HEK-293T
cells that received AM251 and serotonin each time. Images are representative of over 50 images collected for each treatment. For all panels,
pairwise comparisons are indicated:  P , 0.001. EGFP, enhanced green ﬂuorescent protein; GPCR, G protein-coupled receptor.
1702 | P. Reis Rodrigues et al.
nonselective CB1/2 agonists CP55,940 (Pertwee 1999) had no effect,
while O-2545 (Martin et al. 2006) showed the greatest potency, and the
CB2 receptor agonist GP1a (Murineddu et al. 2006) exhibited a low
level of inhibitory activity against AM251. A caveat to interpreting these
data are the fact that certain chemical structures accumulate more
effectively in the worm than others (Burns et al. 2010), and thus those
compounds that show weak effects in the worm may simply be those
that are taken up poorly. However, taken together, these observations
Figure 6 Other CB receptor agonists and antagonists inﬂuence dauer formation in daf-2 mutants. (A–C) CB receptor antagonists promote
reproductive growth in daf-2(e1368) at 25: (A) LH21 is a silent CB1 antagonist. (B) AM630 is a selective CB2 antagonist. (C) URB447 is a mixed
central CB1 receptor antagonist/peripheral CB2 agonist. (D) The growth-promoting effect of 2.5 mM AM251 in daf-2(e1368) is inhibited by the
presence of the nonselective CB1/CB2 agonist O-2545. (E) The growth-promoting effect of 2.5 mM AM251 in daf-2(e1368) is partially inhibited by
the presence of the CB2 selective agonist GP1a. (F) The growth-promoting effect of 2.5 mM AM251 in daf-2(e1368) is not affected by the
presence of the nonselective CB1/CB2 agonist CP55,940. (G) O-2545 alone promotes dauer formation in daf-2(e1368) at the semipermissive
temperature of 23.6. (H) Induction of dauer formation by 25 mM O-2545 in daf-2(e1368) at 23.6 is not affected by deletion of the ascaroside
receptors srbc-64 and srbc-66. Pairwise comparisons are indicated:  P , 0.001. CB, cannabinoid; CON, control.
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suggest that, if the CB agonists and antagonists are binding to a
common receptor in worms, it appears to share some of the phar-
macology of both CB1 and CB2 receptors.
In conclusion, we performed a chemical screen for bioactive lipids
that modify the dauer phenotype in C. elegans, and identiﬁed a CB
receptor antagonist as a potent suppressor of dauer formation. These
studies establish the nematode as a genetically tractable model system
that is responsive to synthetic CBs, and therefore could be useful in
delineating the classical and nonclassical actions of CB-based therapeu-
tics. The fact that a CB1 receptor agonist and antagonist have opposing
effects on the same phenotype in C. elegans makes it tempting to
speculate that they are acting at a common target. In this respect, there
is evidence for the existence of CB receptors inmammals that are distinct
from the canonical CB1 and CB2 receptors (Pertwee et al. 2010, Brown
2007). Ultimately, studies aimed at identifying the molecular targets
of AM251 and O-2545 in C. elegans will be required to determine
whether the effects of these molecules are mediated via non-CB receptor
mechanisms, or via an as yet unidentiﬁed noncanonical CB receptor.
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